Introduction
Anal cancer is a relatively uncommon malignancy. Since the anorectal transitional zone shares an embryonic origin with the uterine cervix, human papillomavirus (HPV) infection is also a major cause of anal cancer as well as cervical cancer. Other known risk factors are human immunodeficiency virus (HIV) infection with low cluster of differentiation 4 (CD4) count, anoreceptive intercourse, cigarette smoking (Etienney et al., 2008; Baranoski et al., 2012) , frequent sexuality, uncircumcised partner and other HPV-related cancers such as women with cervical cancer, vaginal cancer, or vulvar cancer (American Cancer Society, 2014) . Additionally, women with HIV infection had more than 5 and 14 times to develop cervical and anal cancer comparing to the general population, respectively (Chaturvedi et al., 2009 lesion (SIL) the same as cervical cancer. Anal SIL or anal intraepithelial neoplasia (AIN) was categorized to low and high grade. Low grade AIN was likely to rapidly progress to high grade AIN (Palefsky et al., 1998) . In several cases with biopsy-proven SIL, atypical squamous cells of undetermined significance (ASC-US) may also be detected by anal cytological examination (Gaisa et al., 2014) .
According to the World Bank data, there was 1.1% population with HIV infection in Thailand in 2013. The prevalence of abnormal anal Pap test in HIV-infected women in our institute is 2.2% (Pittyanont et al., 2014) . As a result, anal cancer screening program could help to prevent anal cancer in a high-risk population. Unfortunately, there was no routine anal cytology screening program implemented in any Thai hospitals. The objective of this study is to investigate the relationship of cervical and anal cytological screening in HIV-infected women who attended gynecological clinic.
Materials and Methods
This was a descriptive prospective study. Correlation study of dysplastic cells between cervical and anal Pap test in HIV-infected women was performed include of their risk factors. After the study was approved by Prapokklao Hospital Ethics committee, data were collected from HIV-infected women who came for a routine checkup at Prapokklao Hospital HIV-Gynaecological Clinic, Chanthaburi province, Thailand. Period of study was from March 2013 to February 2014. All participants volunteered in this study have signed written consent forms. Then, each individual was given a self-administered questionnaire. Those who could not read proficiently were personally interviewed by the physicians to help them answering the questionnaires.
All women with confirmed diagnosis of HIV infection who visited our HIV-Gynaecological Clinic during the study period were included in this study. Participants with active lower gastrointestinal bleeding, anal inflammation, acute anal fissure and those who did not want to participate were excluded.
Anal Pap test was collected using a long side of modified Ayre's spatula (Chaves et al., 2012) . The spatula was inserted into the anal canal for 2 cm. then rotated 360 degree in a conical motion and removed. Sample was smeared onto a glass slide and immediately fixed in 95% ethyl alcohol for 15 minutes. Air dried samples were transported to the laboratory and reviewed by cytopathologists.
Anal cytological results were classified as satisfactory for evaluation, negative for intraepithelial lesion or malignancy (NILM), atypical squamous cells of undetermined significance (ASC-US), low grade squamous intraepithelial lesion (LSIL), high grade squamous intraepithelial lesion (HSIL) and cancer. Evaluation criteria for cervical cytology used in this study were followed 2001 Bethesda System Terminology (Solomon et al., 2004) . Women with abnormal cervical cytology were sent for colposcopic evaluation and biopsy was taken if indicated.
Women who had abnormal anal cytologic results of equal to, or over "abnormal squamous/glandular cells of undetermined significance" (ASC-US or AGUS) were contacted for further HPV testing. HPV testing was performed using a commercially available kit of Cervista human papillomavirus high risk (HPV HR) assays (Hologic, Inc, Marlborough, MA, USA). If HPV HR testing showed positive for high risk HPV, the second step of HPV testing using Cervista HPV 16/18 assays kit (Hologic, Inc, Marlborough, MA, USA) was performed. This HPV testing method is analyzed by polymerase chain reaction (PCR) techniques according to the manufacturer's guidelines. Subsequently, the patients were referred to the department of surgery (colorectal) for anoscopy and biopsy if indicated. They were further followed-up by surgeons in department of surgery if biopsy results showed anal dysplasia Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) version 19.0 (SPSS, Chicago, IL, USA). Frequency, percentage and the average mean were represented according to demographic characteristics. Chi-square test was used to compare categorical data. Logistic regression analysis was used to evaluate the correlation between both groups and p-value of less than 0.05 was defined as statistical significance.
Results
In this study, 599 participants were enrolled. All were HIV-infected patients who came for routine followup program at Prapokklao Hospital. Mean age of the participants was 40.9±8.9 years with the range of 19 to 70 years old. Ninety percent of them were older than 30 years old. Majority worked for local businesses and 30.7 percent of them worked in agriculture and proprietary trade. Only 5 percent of the participants had undergraduate degrees while the rest of them were primary or secondary school graduates. Multiparous participants were the largest group of the population. Condom was used in 64.9 percent of the participants and homosexual behavior was accounted for 1.4 percent (8/599). Alcohol consumption and smoking habit were found only 3 and 1.7 percent, respectively. Most of the participants had CD4 count more than 200 per mm3. Ninety five percent of them had no history of other sexual transmitted diseases. A comparison of demographic and characteristic data with reference to cervical and anal cytology is presented in Table 1 .
Inadequacy of the collected specimen for evaluation was 34.4% (206/599). After exclusion of cases with low-quality samples Pap test, three hundred and ninety three patients were still participated in the study. Table  1 showed characteristics associated with abnormal anal Pap test comparing to negative anal Pap test. Duration of seropositive, condom usage and abnormal cervical Pap test were statistically significant when associated with abnormal anal Pap test with p-value at 0.002, 0.045 and less than 0.001, respectively. Participants' age, occupation, education, family status, history of sexual transmitted diseases, smoking habit, alcohol consumption and CD4 count had no significant correlation to the occurrence of abnormal anal Pap test.
The prevalence of abnormal cervical and anal Pap test of HIV-infected women in this study were 19.4 (116/599) and 2.3 (14/599) percent. Table 2 shows data for sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of cervical and anal Pap test which were found to be 93.9/12.0, 87.3/96.9, 39.7/21.4, 99.4/94.1 and 88.1/91.4 percent, respectively. 
Discussion
Anal cancer is a rare disease with 0.3% increase in incidence per year from 2004 through 2008 (Siegel et al., 2012) . Known risk factors of anal cancer include HPV infection (Ghosh et al., 2012; Afshar et al., 2013) , HIV infection with low CD4 count, anoreceptive intercourse and cigarette smoking (Baranoski et al., 2012; Zhang et al., 2012) . When concerned about cervical cancer screening, Pap test is widely accepted as an effective screening tool for cervical precancerous lesion and cancer. It significantly helps lowering the mortality from cervical cancer. However, colposcopic-directed biopsy is still the gold standard for cervical cancer diagnosis in women with abnormal cervical cytology. In the USA, there is still no definite guideline or recommendation on anal cytologic screening offered for AIN which may progress to anal cancer (MMWR Recommendations and Reports, 2009) . Currently, there is also no anal cancer screening program in Thailand.
Human immunodeficiency virus (HIV) infection with low CD4 count, anoreceptive intercourse, cigarette smoking (Etienney et al., 2008; Baranoski et al., 2012) , frequent sexuality, uncircumcised partner, number of sexual partner and other HPV-related cancer such as women with cervical cancer, vaginal cancer, or vulvar cancer (Centers for Disease Control and Prevention, 2014) were reported to be risk factors for anal cancer. People with lower nadir CD4 counts appear to be at higher risk of anal cancer (Bertisch et al., 2013) . This was the same as in this study when the risks of abnormal anal cytology were concerned. In this study, the duration of seropositive, condom usage and abnormal cervical cytology had significant relation to the occurrence of abnormal anal cytology. The CD4 count, smoking habit and alcohol consumption did not show any significant effect to abnormal anal cytology.
Anoreceptive intercourse was found in 36-42% of HIVinfected women in the United States (Conley et al., 2010; Kojic et al., 2011) . In our previous study, the prevalence of anoreceptive intercourse is only 0.7% which is fairly low (Pittyanont et al., 2014) . Since, by culture, Thai people are timid to talk about sexual subject (Suwannarurk et al., 2009) , acceptance of culturally non-approved sexual conduct such as anoreceptive intercourse may be denied. Other than immune-compromised condition such as HIV infection, oncogenic HPV serotypes especially HPV-16, plays an important role in anal cancer development (Centers for Disease Control and Prevention, 2014) .
HIV-infected women have more than 5 times higher risk to have cervical cancer (standardized incidence ratio [SIR] 5.6) and more than 13-14 times higher risk to have anal cancer than general (SIR 13.1-14.5) (Piketty et al., 2012) . Tissue around anal region is structurally similar to that of cervicovaginal region. Therefore, abnormal cervical cytology plays an important role for development of abnormal anal cytology. Our study suggests that HIVinfected women with abnormal cervical cytology had 3.8 higher risk to have abnormal anal cytology. Our result is consistent with the previous study by Lamme et al. (2014) . High-grade AIN was also likely to be detected in anal cytology from HIV-infected individuals as well (Mullins et al., 2013) .
Presently, anal cytology is still used by most to screen for anal cancer. But because of low sensitivity made it's not suitable for screening tool. Ferraris and coworker reported a low specificity and low sensitivity for Pap test in detecting abnormal anal cancer. It is imprudent to terminate a close anoscopic surveillance in high-risk patients based on only the normal Pap test result (Ferraris et al., 2008) . In this study, the sensitivity of anal Pap test was only 12.0%. This was different from 93.9% sensitivity of cervical Pap test. Fortunately, the anal Pap test had high specificity and high negative predictive value (96.9% and 94.1%, respectively) which could be used as diseaseexclusion tool. Since 34.4% of the samples collected in this study had low quality (206/599), improvement of specimen collection should be concerned. Anal Pap test is not routinely offered in Thailand. This result might be from the number of poor sample, however the specificity of the screening test was good. Stool softener or enema introduced before the specimen collection and modification the shape of spatula might be in consideration for next study.
Anal HPV also correlated with abnormal anal cytology. Our study supported the correlation of cervical and anal HPV infection as previously reported (Lamme et al., 2014) . Previous study indicated that women with highrisk cervical HPV were more likely to have high-risk anal HPV with odds ratio of 3.6. Additionally, women with high-risk anal HPV were more likely to have abnormal anal cytology with odds ratio of 6.5. Although this study had a higher number of participants, there were more cases of unsatisfied Pap test when compared to the previous study (206[34.4%] : 29[14.8%]). Another contributing factor was the number of HIV-infected cases that in this study, we include only HIV-infected women not normal participants.
In this study, a fair numbers of abnormal anal cytology was detected. However, the report of anoreceptive intercourse in Thai women is fairly low. This might be from Thai culture and patients' embarrassment to reveal the practice of intercourse. In 2013, the number of adult Thai men with HIV was 257,293, with 5,899 new infected cases. This number was higher than women data. Although HIV prevalence among male sex workers declined from 16.0% in 2010 to 12.2% in 2012, it remained significantly 19% higher than female sex workers and 20% higher than general men who have sex with men (MSM) population (Thai National Aids Committee, 2014). HIV prevalence among MSM is still high, especially among those living in large urban areas and international tourist destinations (e.g., Bangkok, Chiang Mai, Phuket, Pattaya). Therefore, anal cytology or anal HPV testing might be a promising screening tool for anal cancer especially in a high-risk population. A patient receptive system and protocol should be suggested in the future.
In conclusion, abnormal cervical cytology in HIVinfected women had 3.8 times higher risk for abnormal anal cytology while shorter duration of seropositive brought a higher risk for anal intraepithelial neoplasia. There is no standard recommendation for anal cancer screening in HIV-infected women. However the increasing incidence of the disease makes it a priority to initiate anal cancer screening standard protocol. Sensitivity of anal Pap test for detection of AIN2/3 is low though specificity is excellent. Inadequate specimen received for further evaluation is a major limitation. Improvement of sample collection is recommended for future investigation since anal cytological screening should be a routine service offering to both male and female population with high-risk HPV infection in the near future.
